[96a5a0]: / output / allTrials / logical / NCT02000531_logical.json

Download this file

142 lines (142 with data), 5.3 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
{
"info": {
"nct_id": "NCT02000531",
"official_title": "Ensure Extension Study to Assess the PFS of First-Line Erlotinib (Tarceva®) and Erlotinib After the Time of Disease Progression in Chinese Population Enrolled in the Ensure Trial",
"inclusion_criteria": "* Participant in ENSURE trial\n* Disease progression during first-line treatment\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* N/A",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"identified_line": {
"line": "* Participant in ENSURE trial",
"criterions": [
{
"exact_snippets": "Participant in ENSURE trial",
"criterion": "ENSURE trial participation",
"requirement": {
"requirement_type": "participation",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Participant in ENSURE trial",
"criterion": "ENSURE trial participation",
"requirement": {
"requirement_type": "participation",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Disease progression during first-line treatment",
"criterions": [
{
"exact_snippets": "Disease progression during first-line treatment",
"criterion": "disease progression",
"requirement": {
"requirement_type": "timing",
"expected_value": "during first-line treatment"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Disease progression during first-line treatment",
"criterion": "disease progression",
"requirement": {
"requirement_type": "timing",
"expected_value": "during first-line treatment"
}
}
]
}
},
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
}
}
],
"exclusion_lines": [
{
"identified_line": {
"line": "* N/A",
"criterions": []
},
"logical_structure": {
"and_criteria": []
}
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}